Trial intelligence / Profile preview

Collagen vs Lidocaine vs Saline for Myofascial Pain in TMD

NCT03323567Phase 1Completed

Sponsor
Medical University of Silesia
Start
Jan 2016
Primary completion
Oct 2017
Modality
Biologic
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of MD-MUSCLE in temporomandibular joint disorders (TMD) (3 arms), sponsored by Medical University of Silesia. Primary endpoint: Reduction of sEMG activity of masseter muscles at 14 days. Started Jan 2016; status: completed.

02

Drugs

MD-MUSCLE
03

Conditions

temporomandibular joint disorders (TMD)

Beyond the preview

Go deeper on NCT03323567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03323567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call